Paras Healthcare Limited, the operator of the Paras Health hospital network, is preparing to enter the Indian stock market through a ₹1,450 crore initial public offering. The Gurugram-based healthcare company provides specialised hospital services across North India, Bihar and Jharkhand, with a focus on tertiary and quaternary medical care.
The Paras Healthcare IPO Open Date is October 21, 2026, while the IPO Close Date is October 23, 2026. The company filed its Red Herring Prospectus on October 14, 2026, confirming the issue schedule and structure.
The offering includes a ₹500 crore fresh issue and a ₹950 crore Offer for Sale (OFS). Unlike an entirely OFS-based IPO, Paras Healthcare will receive fresh capital that it intends to use primarily for debt repayment and general corporate purposes.
Paras Healthcare IPO Details
| IPO Details | Information |
|---|---|
| Company Name | Paras Healthcare Limited |
| Hospital Brand | Paras Health |
| IPO Type | Mainboard IPO |
| Issue Type | Book Built Issue |
| IPO Open Date | October 21, 2026 |
| IPO Close Date | October 23, 2026 |
| Total Issue Size | ₹1,450 crore |
| Fresh Issue | ₹500 crore |
| Offer for Sale | ₹950 crore |
| Face Value | ₹1 per share |
| Price Band | Awaiting announcement |
| Lot Size | Awaiting announcement |
| Minimum Investment | To be determined |
| Anchor Investor Date | October 19, 2026 |
| Expected Allotment Date | October 26, 2026 |
| Expected Listing Date | October 28, 2026 |
| Listing Exchanges | BSE and NSE |
| Lead Managers | JM Financial, BofA Securities India, Nuvama Wealth Management |
The final price band and lot size were not confirmed in the available announcements at the time of writing on October 15, 2026. The company is expected to disclose the pricing details ahead of the subscription period.
Also Read: Jio Platforms IPO Details: Price Band, Dates, Issue Size, Financials, GMP and Business Model
The IPO size has been reduced from the ₹1,800 crore proposed in its earlier draft documents. The revised offer consists of ₹500 crore in fresh equity and ₹950 crore in shares being sold by existing shareholders.
What Does Paras Healthcare Do?
Paras Healthcare operates a network of multispeciality hospitals under the Paras Health brand. Its business focuses on providing advanced medical treatment, hospitalisation, surgical procedures, diagnostic services and critical care.
The company operates in the tertiary and quaternary healthcare segments. Tertiary care involves specialised treatment for complex medical conditions, often requiring advanced equipment and specialist physicians. Quaternary care includes highly specialised procedures and treatment programmes that may be available only at selected hospitals.
Paras Healthcare offers services across multiple clinical disciplines, including cardiology, oncology, neurology, neurosurgery, orthopaedics, gastroenterology, nephrology and critical care.
Also Read: Tonbo Imaging India IPO Details: Price Band, Dates, Financials, GMP and Business Model
Its hospital business generates revenue from inpatient treatment, surgical procedures, outpatient consultations, diagnostics and other healthcare services. Revenue depends on factors such as patient volumes, occupancy levels, the mix of medical procedures and revenue generated per occupied bed.
The hospital chain’s business model requires continuous investment in medical infrastructure, technology, skilled professionals and service quality.
Hospital Network and Geographic Presence
Paras Healthcare operates eight hospitals with a combined capacity of approximately 2,211 beds. Its network is concentrated in North India, Bihar and Jharkhand.
This regional presence allows the company to serve patients across large urban centres and surrounding markets. Specialised hospitals can attract patients from nearby cities and districts where advanced treatment facilities may be limited.
Also Read: Zetwerk Manufacturing Business IPO Details: Price Band, Dates, Financials, GMP and Business Model
Geographic concentration also presents operational advantages. Hospitals operating within a regional network may benefit from shared procurement, medical expertise, management systems and brand recognition.
However, dependence on particular regions creates exposure to local competition, healthcare regulations and changes in patient demand.
Paras Healthcare plans to expand its hospital network through additional facilities in Gurugram and Ludhiana.
Hospital Expansion Plans
The company has outlined plans to develop a 300-bed hospital in Gurugram and a 600-bed hospital in Ludhiana. These facilities are expected to increase its total capacity to approximately 3,011 beds by March 2028, subject to execution and commissioning schedules.
Also Read: Bonfiglioli Transmissions IPO Details
Hospital expansion can create opportunities for long-term revenue growth by increasing the number of patients a healthcare provider can accommodate.
However, new hospitals generally require substantial investment before reaching stable occupancy and profitability. Expenses associated with medical equipment, staffing, maintenance and infrastructure may begin before patient volumes reach mature levels.
The financial performance of new facilities will therefore depend on occupancy growth, physician recruitment, local demand, clinical services and operating efficiency.
Paras Healthcare Financial Performance
Paras Healthcare reported a significant improvement in its financial performance during FY2026, moving from a net loss in the previous year to profitability.
Also Read: Sahajanand Medical Technologies IPO Details
| Financial Metric | FY2025 | FY2026 |
|---|---|---|
| Revenue | ₹1,294 crore | ₹1,606 crore |
| Profit After Tax | −₹57.9 crore | ₹43.8 crore |
Revenue increased approximately 24.1% in FY2026. The company also reported a profit after tax of ₹43.8 crore, compared with a loss of ₹57.9 crore in FY2025.
The turnaround indicates an improvement in reported profitability, although investors should examine the contribution of hospital operations, finance costs, depreciation and other financial items before assessing the sustainability of earnings.
For the quarter ended June 30, 2026, the company reported revenue of approximately ₹470.3 crore, compared with ₹368.4 crore in the corresponding quarter of the previous year.
Quarterly revenue increased approximately 27.7%, while profit after tax reached ₹49.6 crore, compared with a loss of approximately ₹1 crore in the year-earlier period.
Also Read: Fusion CX IPO Details: Price Band, Dates, Financials and Key Risks
The June-quarter profit was higher than the profit reported for the entire preceding financial year. This makes it particularly important to examine the quarterly financial statements and understand whether the improvement reflects recurring operating performance or other contributing factors.
IPO Structure and Selling Shareholders
The Paras Healthcare IPO comprises a fresh issue of ₹500 crore and an Offer for Sale of ₹950 crore.
Under the OFS component, promoter Dr Dharminder Kumar Nagar intends to sell shares worth approximately ₹300 crore, while Commelina Limited, an affiliate of private equity investor Creador, will sell shares worth approximately ₹650 crore.
Before the offering, Dr Nagar held approximately 72.8% of the company. Other shareholders included Commelina, 360 ONE investment entities and Axis New Opportunities AIF.
Also Read: HD Fire Protect IPO Details
The OFS will provide an opportunity for existing shareholders to partially monetise their investments. However, the proceeds from these share sales will not be received by Paras Healthcare.
Use of IPO Proceeds
Paras Healthcare plans to utilise approximately ₹375 crore from the fresh issue proceeds towards repayment or prepayment of outstanding borrowings.
The company reported consolidated outstanding fund-based debt of approximately ₹888.9 crore. Reducing debt could lower future interest expenses and improve financial flexibility.
The remaining fresh issue proceeds, after applicable expenses, are intended for general corporate purposes.
Also Read: Vishal Nirmiti IPO Details
Debt reduction is particularly relevant for hospital operators because healthcare infrastructure requires substantial capital investment. Medical equipment, buildings, diagnostic facilities and hospital expansion can create significant financing requirements.
However, debt repayment does not automatically guarantee stronger profitability. Future performance will continue to depend on hospital occupancy, operating efficiency, medical costs and capital expenditure.
Healthcare Industry and Growth Opportunities
India’s organised hospital industry offers opportunities associated with rising demand for specialised medical treatment, increasing healthcare awareness and the expansion of private healthcare infrastructure.
Paras Healthcare’s focus on tertiary and quaternary services positions it within segments requiring specialised physicians, advanced medical equipment and complex treatment capabilities.
Also Read: Nityas Gems & Jewellery IPO Details
Demand for cardiac care, oncology, neurology and other specialised medical services may support patient volumes as healthcare access expands.
The company’s planned capacity expansion could also increase its ability to serve patients in existing and new markets.
Nevertheless, expanding bed capacity does not automatically translate into proportional revenue growth. New hospitals must attract patients, build clinical teams and gradually improve utilisation.
Key Risks
One important risk is the capital-intensive nature of hospital operations. Establishing and operating hospitals requires significant investment in infrastructure, medical equipment and qualified professionals.
Also Read: SRIT India IPO Details
The company also faces execution risks associated with its planned expansion. Delays in construction, regulatory approvals, equipment installation or physician recruitment could affect the expected contribution from new hospitals.
Competition is another consideration. Paras Healthcare competes with established hospital chains, regional healthcare providers and specialised medical institutions.
Profitability may also be influenced by employee expenses, medical consumable costs, insurance reimbursement arrangements and the pricing of healthcare services.
The company’s financial history deserves attention. Although it returned to profitability in FY2026, it reported a loss in FY2025. Investors should examine cash flows and operating performance across multiple years rather than relying on a single profitable period.
Also Read: Shah Investor’s Home IPO Details
Finally, healthcare providers face regulatory, clinical and reputational risks. Patient safety, treatment quality, medical compliance and the availability of qualified healthcare professionals are essential to maintaining operations.
Paras Healthcare IPO GMP
As of the morning of October 15, 2026, a reliable numerical grey market premium for the Paras Healthcare IPO could not be established.
The grey market premium is an unofficial indicator of sentiment before listing. It is not published by the stock exchanges and may change considerably as the subscription period approaches.
Investors should not treat GMP as a guaranteed listing return. The company’s valuation, financial performance, debt position, hospital expansion plans and official IPO disclosures are more relevant to evaluating the business.
Also Read: AceVector IPO Details: Price Band, Dates, Financials, GMP and Key Risks
Financial Disclaimer: This article is published by Onetrader.in for educational and informational purposes only. It does not constitute investment advice, a recommendation to subscribe to or avoid an IPO, or a guarantee of listing gains or future returns. Onetrader is not a SEBI-registered investment adviser or research analyst. Investors should read the company’s Red Herring Prospectus, assess the associated risks and consult a qualified financial professional before making investment decisions.
Keep learning with OneTrader
Explore structured lessons and practical guides to build your market knowledge.